Tempus AI, Inc. (TEM)
71.13
+2.81
(+4.11%)
USD |
NASDAQ |
Oct 15, 16:00
71.65
+0.52
(+0.73%)
After-Hours: 05:51
Tempus AI Research and Development Expense (Quarterly) : 96.57M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.57M |
| March 31, 2026 | 94.16M |
| December 31, 2025 | 90.62M |
| September 30, 2025 | 83.05M |
| June 30, 2025 | 76.10M |
| March 31, 2025 | 69.26M |
| December 31, 2024 | 61.48M |
| September 30, 2024 | 58.03M |
| June 30, 2024 | 145.93M |
| March 31, 2024 | 51.41M |
| Date | Value |
|---|---|
| December 31, 2023 | 48.74M |
| September 30, 2023 | 47.39M |
| June 30, 2023 | 45.60M |
| March 31, 2023 | 43.76M |
| December 31, 2022 | 42.44M |
| December 31, 2021 | 36.28M |
| September 30, 2021 | 31.98M |
| December 31, 2020 | 26.17M |
| September 30, 2020 | 23.59M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Personalis, Inc. | 16.34M |
| 10X Genomics, Inc. | 56.79M |
| Twist Bioscience Corp. | 18.02M |
| Moderna, Inc. | 588.00M |
| IQVIA Holdings, Inc. | -- |